MetaADEDB 2.0 @ LMMD
Lisdexamfetamine Dimesylate
(VOBHXZCDAVEXEY-JSGCOSHPSA-N)
Structure
SMILES
NCCCC[C@@H](C(=O)N[C@H](Cc1ccccc1)C)N
Type(s)
Approved; Investigational
ATC code(s)
N06BA12
Molecular Formula:
C15H25N3O
Molecular Weight:
263.379
Log P:
2.9816
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
3
TPSA:
81.14
CAS Number(s):
608137-32-2
Synonym(s)
1.
Lisdexamfetamine Dimesylate
2.
Elvanse
3.
Lis-dexamfetamine Dimesylate
4.
Lisdexamfetamine
5.
NRP-104
6.
NRP104
7.
Vyvanse
8.
Dimesylate, Lis-dexamfetamine
9.
Dimesylate, Lisdexamfetamine
10.
Lis dexamfetamine Dimesylate
11.
NRP 104
External Link(s)
MeSHD000069478
PubChem Compound11597698
ChEBI135925
CHEMBLCHEMBL1201222
DrugBankDB01255
DrugCentral4135
IUPHAR/BPS Guide to PHARMACOLOGY7213
KEGGdr:D08130
Therapeutic Target DatabaseD00DEF
ZINC11680943
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AngioedemaFAERS: 1SIDER
US FAERS
2Chest PainFAERS: 1US FAERS
3Drug screen positiveFAERS: 1US FAERS
4HeadacheFAERS: 1SIDER
US FAERS
5MydriasisFAERS: 1SIDER
US FAERS
6NauseaFAERS: 1SIDER
US FAERS
7SomnolenceFAERS: 1SIDER
US FAERS
8Toxicity to various agentsFAERS: 1US FAERS
9TremorFAERS: 1SIDER
US FAERS
10Urine amphetamine positiveFAERS: 1US FAERS
11VomitingFAERS: 1SIDER
US FAERS
12Weight decreasedFAERS: 1SIDER
US FAERS
13Acute Coronary SyndromeSIDER
14AgitationSIDER
15Anaphylactic shockSIDER
16AnorexiaSIDER
17AnxietySIDER
18AstheniaSIDER
19BruxismSIDER
20Cerebrovascular accidentSIDER
21ConstipationSIDER
22DermatitisSIDER
23DiplopiaSIDER
24Disturbance in sexual arousalSIDER
25DizzinessSIDER
26DyspepsiaSIDER
27Erectile dysfunctionSIDER
28Erythema MultiformeSIDER
29Euphoric moodSIDER
30FatigueSIDER
31Feeling jitterySIDER
32HepatitisSIDER
33HypersensitivitySIDER
34Initial insomniaSIDER
35MalnutritionSIDER
36Middle insomniaSIDER
37Myocardial InfarctionSIDER
38NervousnessSIDER
39PalpitationsSIDER
40Stevens-Johnson SyndromeSIDER
41Sudden deathSIDER
42TachycardiaSIDER
43Toxic Epidermal NecrolysisSIDER
44UrticariaSIDER
45Ventricular hypertrophySIDER
46Visual ImpairmentSIDER
47Visual disturbanceSIDER
48nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.